{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T04:57:58Z","timestamp":1765601878554,"version":"3.48.0"},"reference-count":50,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Health & Medical Research Council\/Rare Cancers Rare Diseases, Unmet Need - COVID 19 (MRFF) application","award":["ID 2006024"],"award-info":[{"award-number":["ID 2006024"]}]},{"name":"ANID Fondecyt Regular","award":["1221837"],"award-info":[{"award-number":["1221837"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,3,28]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Increasing awareness of the high frequency, wide spectrum and disabling nature of symptoms that can persist following COVID-19 infection has prompted the investigation of management strategies. Our study aims to determine the effectiveness of atorvastatin on cognitive function, physical activity, mood, health-related quality of life and features of neurovascular impairment and neuroinflammation in adults with ongoing neurological symptoms after COVID-19 infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy study is an ongoing international, investigator-initiated and conducted, multicentre, prospective, randomised, open label, blinded endpoint trial with fixed time points for outcome assessments. A total of 410 participants with long covid neurological symptoms were planned to be randomly assigned to either the intervention group to receive 40 mg atorvastatin for 12 months or to a control group of no treatment, on top of usual care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study protocol was designed, implemented and reported, in accordance with the International Conference on Harmonisation guidelines for Good Clinical Practice, the National Health and Medical Research Council of Australia, the National Statement on Ethical Conduct in Human Research and with the ethical principles laid down in the World Medical Association Declaration of Helsinki. Central ethics committee approval was obtained from Sydney Local Health District Royal Prince Alfred Hospital Ethics (No: X21-0113 and 2021\/ETH00777 10) in Australia. Site-specific ethics committee approvals were obtained elsewhere before any local study activities. All participants provided written informed consent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      The study protocol is registered at Clinicaltrials.gov (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04904536\">NCT04904536<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-089382","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T11:50:13Z","timestamp":1744631413000},"page":"e089382","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct04904536","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4834-2718","authenticated-orcid":false,"given":"Carlos","family":"Delfino","sequence":"first","affiliation":[{"name":"Centro de Estudios Cl\u00ednicos, Instituto de Ciencias e Innovaci\u00f3n en Medicina (ICIM), Universidad del Desarrollo Facultad de Medicina Cl\u00ednica Alemana, Las Condes, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8942-953X","authenticated-orcid":false,"given":"Cheryl","family":"Carcel","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Lin","sequence":"additional","affiliation":[{"name":"Data science, Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1869-2255","authenticated-orcid":false,"given":"Paula","family":"Mu\u00f1oz-Venturelli","sequence":"additional","affiliation":[{"name":"Centro de Estudios Cl\u00ednicos, Instituto de Ciencias e Innovaci\u00f3n en Medicina (ICIM), Universidad del Desarrollo Facultad de Medicina Cl\u00ednica Alemana, Las Condes, Chile"},{"name":"Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L","family":"Naismith","sequence":"additional","affiliation":[{"name":"Charles Perkins Centre and The University of Sydney, The University of Sydney Brain and Mind Centre, Camperdown, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia"},{"name":"School of Public Health, Imperial College London, The George Institute for Global Health UK, Oxford, Oxfordshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Peters","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirupama","family":"Wijesuriya","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Law","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian H","family":"Harding","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Elliott","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1368-1039","authenticated-orcid":false,"given":"Karin","family":"Leder","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen","family":"Hutchings","sequence":"additional","affiliation":[{"name":"Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7962-9519","authenticated-orcid":false,"given":"Ximena","family":"Stecher","sequence":"additional","affiliation":[{"name":"Departamento de Imagenolog\u00eda, Cl\u00ednica Alemana de Santiago, Facultad de Medicina Cl\u00ednica Alemana Universidad del Desarrollo, Clinica Alemana de Santiago SA, Vitacura, Metropolitan Region, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2672-0949","authenticated-orcid":false,"given":"Sophia","family":"Zoungas","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig S","family":"Anderson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia"},{"name":"Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia"},{"name":"Institute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.1","DOI":"10.1001\/jama.2020.12839.e4"},{"key":"2025121220552715000_15.4.e089382.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m3862","article-title":"Virology, transmission, and pathogenesis of SARS-CoV-2","volume":"371","author":"Cevik","year":"2020","journal-title":"BMJ"},{"key":"2025121220552715000_15.4.e089382.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101762","article-title":"The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis","volume":"55","author":"O\u2019Mahoney","year":"2023","journal-title":"EClinicalMedicine"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.4","DOI":"10.1038\/s41579-022-00846-2"},{"key":"2025121220552715000_15.4.e089382.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264331","article-title":"Characteristics and impact of Long Covid: Findings from an online survey","volume":"17","author":"Ziauddeen","year":"2022","journal-title":"PLoS One"},{"unstructured":"National Institute for Health and Care Excellence (NICE) . COVID-19 rapid guideline: managing the long-term effects of COVID-19. London, 2020. Available: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567261\/","key":"2025121220552715000_15.4.e089382.6"},{"key":"2025121220552715000_15.4.e089382.7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.11417","article-title":"Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review","volume":"4","author":"Nasserie","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025121220552715000_15.4.e089382.8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95565-8","article-title":"More than 50 long-term effects of COVID-19: a systematic review and meta-analysis","volume":"11","author":"Lopez-Leon","year":"2021","journal-title":"Sci Rep"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.9","DOI":"10.1016\/S0140-6736(20)32656-8"},{"doi-asserted-by":"crossref","unstructured":"Zhao S , Martin EM , Reuken PA , et al . Long COVID is associated with severe cognitive slowing: a multicentre cross-sectional study. EClinicalMedicine 2024;68. doi:10.1016\/j.eclinm.2024.102434","key":"2025121220552715000_15.4.e089382.10","DOI":"10.1016\/j.eclinm.2024.102434"},{"key":"2025121220552715000_15.4.e089382.11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jiph.2022.06.013","article-title":"Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis","volume":"15","author":"Pinzon","year":"2022","journal-title":"J Infect Public Health"},{"key":"2025121220552715000_15.4.e089382.12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/acn3.51350","article-title":"Persistent neurologic symptoms and cognitive dysfunction in non\u2010hospitalized Covid\u201019 \u201clong haulers\u201d","volume":"8","author":"Graham","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"2025121220552715000_15.4.e089382.13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084275","article-title":"Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features","volume":"23","author":"Mohamed","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025121220552715000_15.4.e089382.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n1648","article-title":"Long covid-mechanisms, risk factors, and management","volume":"374","author":"Crook","year":"2021","journal-title":"BMJ"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.15","DOI":"10.1136\/jnnp-2019-321913"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.16","DOI":"10.1002\/alz.12644"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.17","DOI":"10.1177\/0271678x221093579"},{"key":"2025121220552715000_15.4.e089382.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117040","article-title":"The association of white matter free water with cognition in older adults","volume":"219","author":"Gullett","year":"2020","journal-title":"Neuroimage"},{"key":"2025121220552715000_15.4.e089382.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-86505-7","article-title":"Free-water diffusion tensor imaging improves the accuracy and sensitivity of white matter analysis in Alzheimer\u2019s disease","volume":"11","author":"Bergamino","year":"2021","journal-title":"Sci Rep"},{"doi-asserted-by":"crossref","unstructured":"Nakaya M , Sato N , Matsuda H , et al . Free water derived by multi\u2010shell diffusion MRI reflects tau\/neuroinflammatory pathology in Alzheimer\u2019s disease. A&D Transl Res & Clin Interv 2022;8. doi:10.1002\/trc2.12356","key":"2025121220552715000_15.4.e089382.20","DOI":"10.1002\/trc2.12356"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.21","DOI":"10.3389\/fmed.2023.1085988"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.22","DOI":"10.1016\/S1473-3099(07)70111-1"},{"key":"2025121220552715000_15.4.e089382.23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/01.ATV.0000163840.63685.0c","article-title":"Statins Reduce Interleukin-6\u2013Induced C-Reactive Protein in Human Hepatocytes: New Evidence for Direct Antiinflammatory Effects of Statins","volume":"25","author":"Arnaud","year":"2005","journal-title":"ATVB"},{"key":"2025121220552715000_15.4.e089382.24","doi-asserted-by":"crossref","first-page":"II18","DOI":"10.1161\/01.CIR.0000129505.34151.23","article-title":"Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?","volume":"109","author":"Sch\u00f6nbeck","year":"2004","journal-title":"Circulation"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.25","DOI":"10.1016\/j.phrs.2014.06.007"},{"key":"2025121220552715000_15.4.e089382.26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13195-017-0237-y","article-title":"Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer\u2019s disease","volume":"9","author":"Geifman","year":"2017","journal-title":"Alz Res Therapy"},{"key":"2025121220552715000_15.4.e089382.27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-24248-8","article-title":"Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis","volume":"8","author":"Chu","year":"2018","journal-title":"Sci Rep"},{"key":"2025121220552715000_15.4.e089382.28","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011304","article-title":"Statins use and risk of dementia: A dose-response meta analysis","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2025121220552715000_15.4.e089382.29","article-title":"Statins for the prevention of dementia","volume":"2016","author":"McGuinness","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.30","DOI":"10.1016\/j.jacc.2019.09.041"},{"key":"2025121220552715000_15.4.e089382.31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/00207454.2013.778846","article-title":"Role of statins in Alzheimer\u2019s disease: a retrospective meta-analysis for commonly investigated clinical parameters in RCTs","volume":"123","author":"Pandey","year":"2013","journal-title":"Int J Neurosci"},{"key":"2025121220552715000_15.4.e089382.32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1211\/146080899128734820","article-title":"Differentiation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors by Their Relative Lipophilicity","volume":"5","author":"Joshi","year":"1999","journal-title":"Pharm Pharmacol Communicat"},{"key":"2025121220552715000_15.4.e089382.33","doi-asserted-by":"crossref","DOI":"10.21037\/atm-22-4565","article-title":"Atorvastatin alleviates oxidative damage by activating the nuclear factor erythroid 2-related factor 2 pathway after brain ischemia in mice","volume":"10","author":"Fan","year":"2022","journal-title":"Ann Transl Med"},{"key":"2025121220552715000_15.4.e089382.34","first-page":"S10","article-title":"Development of a simple screening tool for common mental disorders in general practice","volume":"175","author":"Hickie","year":"2001","journal-title":"Med J Aust"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.35","DOI":"10.1093\/arclin\/acu055"},{"key":"2025121220552715000_15.4.e089382.36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/arclin\/acae042","article-title":"Neurocognitive Impairment in Long COVID: A Systematic Review","volume":"40","author":"Panagea","year":"2025","journal-title":"Arch Clin Neuropsychol"},{"unstructured":"Commissioner O of the . What is a Serious Adverse Event? FDA, 2020. Available: https:\/\/www.fda.gov\/safety\/reporting-serious-problems-fda\/what-serious-adverse-event","key":"2025121220552715000_15.4.e089382.37"},{"key":"2025121220552715000_15.4.e089382.38","first-page":"e1921","article-title":"Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data","volume":"93","author":"Goldman","year":"2019","journal-title":"Neurology (ECronicon)"},{"unstructured":"ICMJE | Home, Available: https:\/\/www.icmje.org\/","key":"2025121220552715000_15.4.e089382.39"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.40","DOI":"10.1016\/0887-6177(94)90018-3"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.41","DOI":"10.1093\/arclin\/acq006"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.42","DOI":"10.1093\/arclin\/acq001"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.43","DOI":"10.1017\/S1355617714000873"},{"key":"2025121220552715000_15.4.e089382.44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/17549507.2016.1276214","article-title":"Changes in semantic fluency across childhood: Normative data from Australian-English speakers","volume":"20","author":"Chami","year":"2018","journal-title":"Int J Speech Lang Pathol"},{"key":"2025121220552715000_15.4.e089382.45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/jmv.27415","article-title":"The COVID-19 Yorkshire Rehabilitation Scale (C19-YRS): Application and psychometric analysis in a post-COVID-19 syndrome cohort","volume":"94","author":"O\u2019Connor","year":"2022","journal-title":"J Med Virol"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.46","DOI":"10.1016\/S0165-0327(03)00198-8"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.47","DOI":"10.1001\/archinte.166.10.1092"},{"doi-asserted-by":"publisher","key":"2025121220552715000_15.4.e089382.48","DOI":"10.1016\/0165-1781(89)90047-4"},{"key":"2025121220552715000_15.4.e089382.49","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.675523","article-title":"Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review","volume":"9","author":"Zhou","year":"2021","journal-title":"Front Public Health"},{"key":"2025121220552715000_15.4.e089382.50","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-018-0642-3","article-title":"Validity of the International Physical Activity Questionnaire (IPAQ) for assessing moderate-to-vigorous physical activity and sedentary behaviour of older adults in the United Kingdom","volume":"18","author":"Cleland","year":"2018","journal-title":"BMC Med Res Methodol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-089382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T04:55:36Z","timestamp":1765601736000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-089382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,14]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1136\/bmjopen-2024-089382"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-089382","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}